Clinical trials
Recruiting Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 16 |
| 2025 | 14 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Beijing GoBroad Hospital | 3 |
| M.D. Anderson Cancer Center | 3 |
| Princess Maxima Center for Pediatric Oncology | 3 |
| The First Affiliated Hospital of Soochow University | 3 |
| Baylor College of Medicine | 2 |
| Hebei Senlang Biotechnology Inc., Ltd. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| St. Jude Children's Research Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 57 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Leukemia | 9 |
| Lymphoma | 8 |
| Lymphoma, T-Cell | 8 |
| Leukemia, Myeloid, Acute | 7 |
| Lymphoma, T-Cell, Cutaneous | 7 |
| Recurrence | 7 |
| Leukemia, Biphenotypic, Acute | 5 |
| Multiple Myeloma | 5 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.